EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

An updated systematic review and meta-analysis of modern radiotherapy techniques for hepatocellular carcinoma

Sun Hyun Bae, Won Il Jang, Jeong Il Yu, Ji Eun Moon, Hee Chul Park, Mi Sook Kim

Liver Cancer · 02.07.2026 · 1-27

DOI: 10.1159/000552470 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Liver Cancer, online erschienen am 02.07.2026. Verfasst von Sun Hyun Bae und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The practice of radiotherapy (RT) is worldwide transitioning from 3-dimensional conformal RT to modern RT techniques for hepatocellular carcinoma (HCC); however, evidence remains insufficient to determine whether these advanced RT techniques improve treatment outcomes. Therefore, we updated the treatment outcomes of modern RT techniques, including intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), and proton beam therapy (PBT), for patients with liver-confined HCC.

Methods

A systematic review of IMRT, SBRT, and PBT was conducted individually following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines to April 2025.

Results

We included 23 IMRT studies comprising 1,479 patients, 22 PBT studies comprising 1,968 patients, and 35 SBRT studies comprising 3,208 patients. When the total doses were converted to the biologically equivalent doses (BED, Gy10), the median BED (mBED) values ranged 48–180 Gy10 (median, 86) for SBRT, 69–110 GyE10 (median, 101) for PBT, and 55–75 Gy10 (median, 67) for IMRT. The pooled 3-year local progression-free survival rates were 64% (95% confidence interval [CI], 45–81%) for IMRT, 89% (95% CI, 86–91%) for PBT, and 86% (95% CI, 82–90%) for SBRT, respectively (p = 0.0076). The pooled 3-year overall survival rates were 19% (95% CI, 11–29%) for IMRT, 55% (95% CI, 48–62%) for PBT, and 65% (95% CI, 57–72%) for SBRT, respectively (p

Zitieren

APA

Bae, S. H., Jang, W. I., Yu, J. I., Moon, J. E., Park, H. C., & Kim, M. S. (2026). An updated systematic review and meta-analysis of modern radiotherapy techniques for hepatocellular carcinoma. Liver Cancer, 1-27. https://doi.org/10.1159/000552470

Vancouver

Bae SH, Jang WI, Yu JI, Moon JE, Park HC, Kim MS. An updated systematic review and meta-analysis of modern radiotherapy techniques for hepatocellular carcinoma. Liver Cancer. 2026:1-27. doi:10.1159/000552470

BibTeX
@article{Bae2026,
  author = {Bae, Sun Hyun and Jang, Won Il and Yu, Jeong Il and Moon, Ji Eun and Park, Hee Chul and Kim, Mi Sook},
  title = {An updated systematic review and meta-analysis of modern radiotherapy techniques for hepatocellular carcinoma},
  journal = {Liver Cancer},
  year = {2026},
  pages = {1--27},
  doi = {10.1159/000552470}
}
Kostenlos starten →